Acetylamantadine Quantification via SERS and Solid Phase Extraction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting and quantifying acetylamantadine in urine samples using liquid chromatography mass spectrometry are time-consuming and costly, necessitating a more efficient and cost-effective approach.
Innovation Solution
The method involves using solid phase extraction to isolate acetylamantadine from urine samples, followed by quantification with substrate-based surface-enhanced Raman spectroscopy, specifically employing methanol elution and a Klarite® SERS substrate for reliable detection.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If liquid chromatography mass spectrometry is used to detect and quantify acetylamantadine, then detection precision is improved, but time consumption and cost increase
Solution Approach 1:
The patent extracts and isolates acetylamantadine from urine samples using solid phase extraction with specific cartridges (C18, HLB, or mixed-mode anion exchange) before analysis. This pre-concentration and purification step enables subsequent rapid detection methods to achieve sufficient precision without requiring time-consuming liquid chromatography separation
Solution Approach 2:
The patent replaces the mechanical separation system of liquid chromatography with Raman spectroscopy-based detection. By using surface-enhanced Raman spectroscopy (SERS) with specific substrates (silver, gold, or copper-based), the method achieves rapid identification and quantification of acetylamantadine without the time-consuming chromatographic separation process
2Measurement precision
If liquid chromatography mass spectrometry is used to detect and quantify acetylamantadine, then detection precision is improved, but cost increases
Solution Approach 1:
The patent employs disposable solid phase extraction cartridges and single-use SERS substrates that are inexpensive and can be discarded after one use. This eliminates the need for expensive, complex liquid chromatography-mass spectrometry systems while maintaining adequate detection precision for clinical screening applications
Solution Approach 2:
The patent substitutes the expensive liquid chromatography-mass spectrometry system with a combination of solid phase extraction and Raman spectroscopy. The SERS technique provides sufficient detection precision at a fraction of the cost, making the overall method economically viable for routine clinical use
3Productivity
If solid phase extraction is used to isolate acetylamantadine, then detection speed is improved, but measurement precision may be affected
Solution Approach 1:
The patent selects specific solid phase extraction cartridges (C18, HLB, or mixed-mode anion exchange) optimized for acetylamantadine recovery, and uses targeted Raman spectroscopy measurement of specific vibrational modes. This localized optimization ensures both rapid processing and accurate quantification without compromising precision
Solution Approach 2:
The patent optimizes extraction parameters including eluent composition (methanol, acetonitrile, or water-methanol mixtures), elution volume, and SERS substrate characteristics to maximize both extraction efficiency and detection sensitivity. By carefully controlling these parameters, the method achieves rapid detection without sacrificing quantification accuracy
Data Source
AI summary
A method for quantifying acetylamantadine in a urine sample comprises eluting acetylamantadine from the urine sample using solid phase extraction and quantifying the acetylamantadine eluted from the urine sample using Raman spectroscopy.